全人工心脏:地平线上的演进
文章旨在明确适合全人工心脏的患者人群、管理策略,并考察处于不同研发阶段的新技术。
要点
- 仅支持左心的装置不能覆盖单心室或双心室衰竭患者。
- 新一代全人工心脏正在研发和评估中,以提供现成解决方案。
- 综述关注全人工心脏适宜人群、管理及在研新技术。
核心结论
- 新一代全人工心脏正在被改进和评估,以期实现为单心室或双心室心力衰竭患者提供现成解决方案的早期愿景。
研究设计与样本
- 本文为叙述性综述,旨在界定更适合全人工心脏的患者人群、探索该队列管理,并考察处于不同研发阶段的新技术。
主要发现
- 耐用的机械循环支持装置已被证明可有效挽救晚期心力衰竭和心源性休克患者。
- 最重要的进展发生在左心室辅助装置的开发上,但仅支持左心的装置对部分患者服务不足。
- 全机械心脏替代的进展落后于左心装置,新一代全人工心脏正在填补尚未满足的临床需求空白。
临床怎么用
- 对于不适合仅行左心支持的单心室或双心室心力衰竭患者,可考虑全人工心脏作为现成解决方案进行评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The vision to develop a mechanical blood pump to support or replace the failing human heart was originally proposed in the late 1950s by Dr DeBakey. Since then, a portfolio of durable devices has been demonstrated to effectively salvage patients with advanced heart failure and cardiogenic shock. Arguably, the most important advances have occurred in the development of left ventricular assist devices. However, there remains an important patient cohort not well served by devices that only support the failing left heart. Advances in total mechanical heart replacement have lagged behind left-sided devices, but a new generation of total artificial hearts is being refined and evaluated to realize the early vision to have an off-the-shelf solution for patients with univentricular or biventricular heart failure. This review is intended to define the patient populations better suited for the total artificial heart, explore management of this cohort, and examine some of the new technologies in various phases of development that may fill the gap in currently unmet clinical need.
引用
- Nair, van der Kaaij, Kluin, et al. Total artificial hearts: an evolution on the horizon. Eur Heart J. 2026. PMID: 42183865. doi:10.1093/eurheartj/ehag395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。